You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Correction: Nemvaleukin Alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Nemvaleukin Alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022019929
Dec 20220699
Jan 20230371
Feb 20230395
Mar 2023080
Apr 20230122
May 20230105
Jun 2023092
Jul 20230106
Aug 2023062
Sep 2023055
Oct 2023054
Nov 20230111
Dec 2023094
Jan 20240146
Feb 2024095
Mar 202401617
Total0468103